Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
biotech
clinical trials
life sciences
national blog main
archive
bial
billy dunn
biogen
drug development
drug prices
drug pricing
europe top stories
evrysdi
gene therapy
genentech
ionis pharmaceuticals
medical
national
national top stories
neurocrine
neurodegeneration
neuroscience
new york top stories
novartis
nusinersen
opicapone
parkinson's disease
recalls
risdiplam
rna drugs
roche
safety
san diego
san diego blog main
san diego top stories
san francisco top stories
spinal muscular atrophy
spinraza
zolgensma
What
daily
3
×
drug
fda
medication
patients
acceptable
add
additional
approved
atrophy
called
carbidopa
combination
comes
control
diabetes
disease
evrysdi
exceeds
experience
follows
friday
gets
green
growing
home
impurity
intended
laboratories
levodopa
lights
limit
liquid
matters
medicine
metformin
muscular
neurocrine
new
nod
Language
unset
Current search:
daily
×
fda
×
@slashgear.com
3 years ago
Diabetes drug metformin recalled yet again: Why that matters
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
